Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today

In the latest close session, Humacyte, Inc. (HUMA) was down 7.69% at $2.28. The stock trailed the S&P 500, which registered a daily loss of 0.4%. Meanwhile, the Dow lost 0.98%, and the Nasdaq, a tech-heavy index, added 0.18%. The company's shares have seen an increase of 2.49% over the last month, surpassing the Medical sector's loss of 1.56% and falling behind the S&P 500's gain of 4.97%.The investment community will be closely monitoring the performance of Humacyte, Inc. in its forthcoming earnings report ...